Last Call for Funding! 🚨 @LobularBCA is collaborating with Conquer Cancer’s EveryGrant to implement Clinical Research Grant program to fund independent physician investigators/research scientists who are committed to conducting preclinical, translational, or clinical ILC research. Apply soon: https://t.co/1JwaTF3ekk
Research Funding Alert! 🚨 The @LobularBCA-Shannon Klingman Lobular Breast Cancer Clinical Research Grants fund independent physician investigators/research scientists who are committed to conducting preclinical, translational, or clinical ILC research. Apply by May 11: https://t.co/W7xYiCCJoz
The Lobular Carcinoma Imaging Research Fellowship grant aims to fund a research project focused on advancing Invasive Lobular Carcinoma Imaging and cultivating new lobular breast disease treatments to improve patient outcomes.
Apply here! https://t.co/ONpanAXAJW
Mason Mitchell-Daniels, COO, @LobularBCA, Dr. Christine Brezden-Masley, @SinaiHealth, and Dr. David Lim, @WCHospital, joined Brenda Cunnington, Managing Director, Americas, @Trayport at @TMXGroup, to open the market to recognize the first ever Global Lobular Breast Cancer Awareness Day, on October 15th.
Invasive lobular carcinoma (ILC), also known as lobular #breastcancer, comprises 15% of all breast cancer diagnoses. Despite this incidence, there has been a lack of attention paid to the disease and a lack of funding for scientific research. October is breast cancer awareness month worldwide; declaring October 15th Global Lobular Breast Cancer Awareness Day – will help raise worldwide awareness of this breast cancer type.
Many scientific studies have confirmed that lobular breast cancer is a distinct breast cancer type and that it behaves differently from the more common non-lobular breast cancers. But, for decades, in part because of the smaller numbers of patients at any one site and the insufficient standardization of the diagnosis for pathologists and radiologists, there has been a paucity of research. Therefore, though quite different, #lobularcancer is treated the same as other non-lobular tumors.
Thrilled to host @LobularBCA at @MSKCancerCenter for our Lobular breast cancer town hall and to commemorate October 15th as Lobular Breast Cancer Awareness day!
NEW Grant opens today!
This grant aims to fund a research project focused on advancing Invasive Lobular Carcinoma Imaging and cultivating new lobular breast disease treatments to improve patient outcomes. Apply here! https://t.co/ONpanAXAJW
LBCA is announcing another ILC grant solicitation for two ILC research grants of $50K each in partnership with the American Society for Clinical Oncology (ASCO) and two generous partners. More info here: https://t.co/nFMbiNUNBy read the RFP here: https://t.co/fsa7LZ03VU
The new $5K sponsorship - the Lobular Breast Cancer Research Abstract Merit Award is announced in collaboration with @aacr_cancerresearch for the best abstracts on lobular breast cancer at SABCS. Read more here: https://t.co/Gp5cznn2QV #lobularbreastcancer#ilcresearch
LBCA is announcing another ILC grant solicitation for two ILC research grants of $50K each in partnership with the American Society for Clinical Oncology (ASCO) and two generous partners. More info here: https://t.co/nFMbiNUNBy read the RFP here: https://t.co/fsa7LZ03VU
Dr. Jason Mouabbi discusses the challenges of treating lobular breast cancer with Dr. Kate Lathrop in this episode of SABCS Snippets, highlighting advances being presented at #SABCS23 to address these challenges. Watch now: https://t.co/ebBOdojh2g @JAMouabbi@AACR @UTHealthSAMDA
Dr. Jason Mouabbi discusses the challenges of treating lobular breast cancer with Dr. Kate Lathrop in this episode of SABCS Snippets, highlighting advances being presented at #SABCS23 to address these challenges. Watch now: https://t.co/ebBOdojh2g @JAMouabbi@AACR @UTHealthSAMDA